Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-03-29 Sale | 2021-03-31 12:30 pm | Urovant Sciences Ltd. | UROV | Robinson James A. Jr. PEO;CEO/Urovant Sciences, Inc. | 8,385 | $0 | $0 | 0 (Direct) | View |
| 2021-03-29 Sale | 2021-03-31 12:30 pm | Urovant Sciences Ltd. | UROV | Haag-Molkenteller Cornelia CMO/Urovant Sciences, Inc. | 141,348 | $0 | $0 | 0 (Direct) | View |
| 2021-03-29 Sale | 2021-03-31 12:30 pm | Urovant Sciences Ltd. | UROV | Legault Pierre Director | 21,480 | $0 | $0 | 0 (Direct) | View |
| 2021-03-29 Sale | 2021-03-31 12:30 pm | Urovant Sciences Ltd. | UROV | BANSAL AJAY See Remarks | 140,098 | $0 | $0 | 0 (Direct) | View |
| 2021-03-29 Sale | 2021-03-31 12:30 pm | Urovant Sciences Ltd. | UROV | Hindman James M. Director | 9,000 | $0 | $0 | 0 (Direct) | View |
| 2021-03-29 Sale | 2021-03-31 12:30 pm | Urovant Sciences Ltd. | UROV | Kurstjens Sef Director | 21,480 | $0 | $0 | 0 (Direct) | View |
| 2021-03-29 Sale | 2021-03-31 12:30 pm | Urovant Sciences Ltd. | UROV | Johnston Walt See Remarks | 109,139 | $0 | $0 | 0 (Direct) | View |
| 2021-03-29 Sale | 2021-03-31 12:30 pm | Urovant Sciences Ltd. | UROV | Smith Bryan E. GC/Urovant Sciences, Inc. | 124,447 | $0 | $0 | 0 (Direct) | View |
| 2021-03-29 Sale | 2021-03-31 12:30 pm | Urovant Sciences Ltd. | UROV | OCAMPO CHRISTINE PAO; CAO/Urovant Sciences,Inc. | 78,781 | $0 | $0 | 0 (Direct) | View |
| 2021-03-29 Sale | 2021-03-31 12:30 pm | Urovant Sciences Ltd. | UROV | POTTER MYRTLE S Director | 21,480 | $0 | $0 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-01-10 Tax Withholding | 2021-01-12 7:02 pm | N/A N/A | Urovant Sciences Ltd. | UROV | Robinson James A. Jr. PEO; CEO/Urovant Sciences, Inc | 4,095 | $16.11 | 8,385 (Direct) | View |
| 2021-01-07 Tax Withholding | 2021-01-08 6:30 pm | N/A N/A | Urovant Sciences Ltd. | UROV | Haag-Molkenteller Cornelia CMO/Urovant Sciences, Inc. | 5,810 | $16.09 | 141,348 (Direct) | View |
| 2021-01-07 Tax Withholding | 2021-01-08 6:29 pm | N/A N/A | Urovant Sciences Ltd. | UROV | Smith Bryan E. GC/Urovant Sciences, Inc. | 4,761 | $16.09 | 124,447 (Direct) | View |
| 2020-07-21 Option Award | 2020-07-23 4:35 pm | N/A 2030-07-21 | Urovant Sciences Ltd. | UROV | Hindman James M. Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2020-07-21 Option Award | 2020-07-23 4:33 pm | N/A 2030-07-21 | Urovant Sciences Ltd. | UROV | Legault Pierre Director | 24,000 | $0 | 36,480 (Direct) | View |
| 2020-07-21 Option Award | 2020-07-23 4:31 pm | N/A 2030-07-21 | Urovant Sciences Ltd. | UROV | POTTER MYRTLE S Director | 24,000 | $0 | 36,480 (Direct) | View |
| 2020-07-21 Option Award | 2020-07-23 4:28 pm | N/A 2030-07-21 | Urovant Sciences Ltd. | UROV | Kurstjens Sef Director | 24,000 | $0 | 36,480 (Direct) | View |
| 2020-06-02 Option Award | 2020-06-03 6:50 pm | N/A 2030-06-02 | Urovant Sciences Ltd. | UROV | Johnston Walt SVP, Commercial, USI | 177,844 | $0 | 177,844 (Direct) | View |
Ownership | 2020-06-03 6:45 pm | N/A N/A | Urovant Sciences Ltd. | UROV | Johnston Walt SVP, Commercial, USI | 0 | $0 | 0 (Direct) | View |
| 2020-06-01 Option Award | 2020-06-01 6:05 pm | N/A 2030-06-01 | Urovant Sciences Ltd. | UROV | Hindman James M. Director | 61,000 | $0 | 61,000 (Direct) | View |
Ownership | 2020-06-01 5:47 pm | N/A N/A | Urovant Sciences Ltd. | UROV | Hindman James M. Director | 0 | $0 | 0 (Direct) | View |